Schedule of Sales and Operating Income by Operating Segment, Excluding Discontinued Operations |
Revenue and operating income (loss) from continuing operations by operating segment are shown in the table below: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | October 3, 2021 | | October 4, 2020 | | October 3, 2021 | | October 4, 2020 | | (In thousands) | Discovery & Analytical Solutions | | | | | | | | Product revenue | $ | 318,456 | | | $ | 245,556 | | | $ | 903,796 | | | $ | 686,529 | | Service revenue | 194,423 | | | 178,067 | | | 576,521 | | | 526,491 | | Total revenue | 512,879 | | | 423,623 | | | 1,480,317 | | | 1,213,020 | | Operating income from continuing operations | 7,146 | | | 42,689 | | | 114,248 | | | 110,632 | | Diagnostics | | | | | | | | Product revenue | 467,413 | | | 491,290 | | | 1,461,384 | | | 1,077,352 | | Service revenue | 186,392 | | | 49,112 | | | 761,143 | | | 137,767 | | Total revenue | 653,805 | | | 540,402 | | | 2,222,527 | | | 1,215,119 | | Operating income from continuing operations | 237,903 | | | 223,819 | | | 965,650 | | | 413,710 | | Corporate | | | | | | | | Operating loss from continuing operations | (23,079) | | | (18,502) | | | (57,664) | | | (56,015) | | Continuing Operations | | | | | | | | Product revenue | 785,869 | | | 736,846 | | | 2,365,180 | | | 1,763,881 | | Service revenue | 380,815 | | | 227,179 | | | 1,337,664 | | | 664,258 | | Total revenue | 1,166,684 | | | 964,025 | | | 3,702,844 | | | 2,428,139 | | Operating income from continuing operations | 221,970 | | | 248,006 | | | 1,022,234 | | | 468,327 | | Interest and other expense, net (see Note 5) | 60,302 | | | 14,249 | | | 54,027 | | | 35,054 | | Income from continuing operations before income taxes | $ | 161,668 | | | $ | 233,757 | | | $ | 968,207 | | | $ | 433,273 | |
|